FINAL-PROGRAM
Print Version (PDF-File, 84 KB)
Friday 18.01.2008
09:00 Starting Registration
10:00 - 11:30 Technician Workshop
- Results of Questionnaire
- Slitlamp Evaluation and Technique
- Corneal Evaluation: Examples and Discussions
- Implementation of QM/QA into routine work at the eye bank under the EU Directive / EEBA technical guidelines
11:30 - 13:30 Lunch & Exhibition & Poster
11:30 - 13:30 Committee Meeting (+ working lunch)
13:30 - 14:30 Official Opening Ceremony
- EEBA President – Prof. Vincent Borderie
- EEBA 2008 Organizers – Prof. Thomas Neuhann & Prof. Anselm Kampik
- Representative of Bavarian Government (Invited)
14:30 - 15:45 Scientific Program Session I:
Donor Selection & Corneal Evaluation and Storage
Chairs: Dr. Elisabeth Pels PhD, Andrea Gareiss-Lok CEBT
Oral Presentations:
- Physical examination of potential cornea donors in Europe (V 1.1)
Caroline Van Geyt, University Hospital Ghent, Belgium
- Impact of donor’s age on immunological graft failure in the baby rat (V 1.2)
Johannes Schwartzkopff MD, University Eye Hospital Freiburg, Germany
- Bleeding complications after enucleation for cornea donation (V 1.3)
Marja Van Wijk MD, PhD, BIS Foundation, Leiden Netherlands
- Influence of temporary hypothermia on corneal endothelial cell density
during organ culture preservation (V 1.4)
Jan Schroeter MD, FEBO, University Hospital Berlin Charité, Germany
- Evaluation of animal component free storage media for corneas
destined for transplantation (V 1.5)
Valerie A. Smith, MD, University of Bristol, Bristol, Great Britain
- Cornea graft endothelial viability assessement using the triple labelling
Hoechst/Ethidium homodimer/Calcein-AM: technical improvements using
3D microscopy (V 1.6)
Gilles Thuret, MD, PhD, Lab.Biology, Saint-Etienne, France
15:45 - 16:15 Coffee Break & Exhibition & Poster
16:15 - 17:30 Scientific Program Session II
Invited Lectures & Clinical Outcome and Adverse Reactions
Chairs: Prof. Vincent Borderie, Prof. Ulrich Welge-Luessen
Invited Lectures:
- International Cooperation for improvement of Organ & Tissue
Transplantation
Bruno Meiser MD, PD, President of Eurotransplant Leiden, Netherlands
- The role of legal medicine in the transplantation process – past and future
Wolfgang Eisenmenger Prof. Dr., Head of Department for Forensic Medicine Ludwig
Maximilian-University Munich, Germany
Oral Presentations:
- Implantation of a new artificial iris implant for aniridia after corneal
transplant (V 2.3)
Angelika Lindenschmid MD, University Eye Hospital Rechts der Isar, Munich, Germany
- Langerhans Cells in corneal graft rejection (V 2.4)
Ivana Mravicic MD, Lions Croatian Eye Bank Zagreb, Croatia
- Clinical experience with DSAEK at Aarhus Universitiy Hospital – first 20
cases with +6months follow-up (V 2.5)
Jesper Hjortdal MD, PhD, University Eye Hospital Aarhus, Aarhus, Denmark
- Causes of primary donor failure in Descemet membrane endothelial
keratoplasty (V 2.6)
Jacqueline van der Wees MD, Netherlands Institute for innovative ocular surgery
NIIOS, Rotterdam, Netherlands
- Bevamizumab (Avastin) infiltrates the cornea during the process of
organ culture (V 2.7)
Alice Yu MD, Eye Bank of University Eye Hospital of Ludwig-Maximilian-University
Munich, Germany
19:00 - 24:00 Dinner Evening
Hacker-Pschorr Bräuhaus, Theresienhöhe 7, 80339 München, Tel. +49-89-500 59 38 00
Saturday 19.01.2008
08:30 - 09:20 Business Meeting
09:20 - 09:30 Presentation of EEBA Meeting 2009
Cornea Bank Amsterdam
09:30 - 09:45 Coffee Break & Exhibition & Poster
09:45 - 12:00 Scientific Program Session III
Invited Lectures & Legal and Ethical Aspects under EU Directive &
Clinical Outcome and Adverse Reactions
Chairs: Prof. Diego Ponzin, Jesper Hjortdal MD, PhD
Invited Lectures:
- Eye Bank Prepared Pre-Cut Tissue in Descemet’s Stripping Endothelial
Keratoplasty: Complications and Early Post-operative Results
Edwin Chen MD, Devers Eye Institute, Portland Oregon USA (V 3.1)
- Eye Banking in Europe: History and Evolution in a single Eye Bank
Juan Alvarez de Toledo MD, Centro de Oftalmologia Barraquer, Barcelona Spain (V3.2)
Oral Presentations:
- International Eye Bank Sofia – new beginning (V 3.3)
Petja Vassileva Prof., University Eye Hospital Sofia, Bulgaria
- Outcome of first 100 cornea donations at the Eye Bank
of Schwerin (HSN) (V 3.4)
Frank Wilhelm MD, Prof., Helios Eye Hospital and Eye Bank Schwerin, Schwerin Germany
- Corneal Transplantation in Iran (V 3.5)
Mozhgan Rezaei Kanavi MD, Central Eye Bank of Iran, Teheran Iran
- Some cost-benefit consideration on the consequences of implementation
of EU-Directive 2004/23/EF in Denmark (V 3.6)
Jesper Hjortdal MD, PhD, University Eye Hospital Aarhus, Aarhus, Denmark
- Corneal Transplantation indications and graft survival in
an Italian cohort of patients: 3-year results from CORneal Transplant
epidemiological study (V 3.7)
Adriano Fasolo MD, Fondazione Banca degli Occhi del Veneto, Venice Italy
- The Outcome of graft endothelial cell density after keratoplasty (V 3.8)
Vincent Borderie MD, Prof., CHNO des XV-XX, Paris France
- Limbal pseudocyst occuring several decades after eye trauma (V 3.9)
Beata Rymgayllo-Jankowska, Medical Supervisor at Lublin Eye Bank, Lublin Poland
- Sterile cellular stromal keratitis following penetrating keratoplasty (V 3.10)
Philip Maier MD, University Eye Hospital, Freiburg Germany
- IL-6, IL-10 and INF-ץ genes polymorphisms and local risk factors in
corneal graft rejection (V 3.11)
Dariusz Dobrowolski MD, District Railway Hospital, Katowice Poland
- Are immunostaining and histological analyses of failed corneal grafts
useful indicators to assess the rejection risk of the re-grafting? (V 3.12)
Adriano Fasolo MD, Fondazione Banca degli Occhi del Veneto, Venice Italy
- Deep Lamellar Keratoplasty – first results after 36 months (V 3.13)
Tobias Neuhann MD, AaM Augenklinik Marienplatz Muenchen, Munich Germany
12:00 - 13:30 Lunch & Exhibition & Poster
13:30 - 14:45 Scientific Program Session IV
Invited Lectures & Companies presentation & Limbal Stem cells /
Tissue Engineering
Chairs: Alice Yu MD, Eveline Schretter-Irschick MD, Prof.
Companies presentation BCB Medical:
- Increased Controll, Transparency and Tissue availability in tissue
Banking with centralized Database software (V 4.1)
Ville Leino, BCB Medical, Turku Finnland
Invited Lectures:
- The artificial cornea – state of the art and perspectives (V 4.2)
Maria Engelke MD, PD, Akademie fuer Tierschutz, Germans protection of animals e.V.,
Neubiberg Germany
Oral Presentations:
- Cultivation of Limbus-Stem-Cells: Techniques & Results (V 4.3)
Norbert Angerbauer Dr.rer.-nat., Hornhautbank Muenchen, Munich Germany
- An up-date on the synthetic collagenous artificial cornea (V 4.4)
Per Fagerholm MD, Prof., University Eye Hospital, Linköping Sweden
- Presentation of the European 3-dimensional reconstruction program
(FP6) of human corneas by tissue engineering (V 4.5)
Patrick Sabatier MD, Banque Francaise des yeux, Paris France
Invited Lectures:
- New markers in tissue culture (V 4.6)
Eveline Schretter-Irschick MD, Prof., University Eye Hospital, Innsbruck Austria
Companies presentation 20/10 Perfect Vision:
- Keratoplasy procedures with the FEMTEC Femtosecond Workstation (V 4.7)
Michael J. Behrend, 20/10 Perfect Vision, Heidelberg Germany
14:45 - 15:15 Coffee Break & Exhibition & Poster
15:15 - 17:00 Scientific Program Session V
New Developments / Techniques in Eye Banking & Sanco-EQSTB
Chairs: Andrea Gareiss-Lok CEBT, Ulrich Welge-Luessen MD, Prof.
Oral Presentations:
- Corneal Cross-Linking in progressive keratoconus, ectasias, marginal
pellucide degeneration – Alternative treatment to keratoplasty? Clinical
evaluation of 15 eyes (V 5.1)
Josef Reiter MD, Augen-Medizinisches Versorgungszentrum Landshut,
Landshut Germany
- Induction of Tissue Transglutaminase and corneal crosslinking (V 5.2)
Niko Kopsachilis MD, University Eye Hospital of Ludwig-Maximilian-University,
Munich Germany
- Application of Nidek Technologies Confoscan-4™ in eye banking (V 5.3)
Alfredo Ruggeri MD, Prof., University of Padova, Padova Italy
- Influence of preoperative endothelial disc preparation on outcomes
of endothelial keratoplasty (V 5.4)
Dominika Janiszewska MD, District Railway Hospital, Katowice Poland
- Cytoprotective Effects of Minocycline on the human endothelium (V 5.5)
Marcus Kernt MD, University Eye Hospital of Ludwig-Maximilian-University,
Munich Germany
- Corneal transplantation layer by layer – a user manual
for eye bankers (V 5.6)
Ilse Claerhout MD, University Eye Hospital Ghent, Ghent Belgium
- Custom Corneal Tissue™ utilizing the Femtosecond Laser and
IntraLase Enabled Keratoplasty™ (V 5.7)
Bernardino Iliakis, SightLife Seattle, Seattle USA
- IntraLase Enabled Keratoplasty IEK – Surgical Technique and
Experience (V 5.8)
Markus Bauer MD, alz Augenklinik muenchen®, Munich Germany
- SANCO – European Quality System for Tissue Banking (V 5.9 – 5.13)
Esteve Trias, Transplant Services Foundation, Barcelona Spain
17:00 - 17:30 Closure of the Meeting
Scientific Posters:
- Bacterial and fungal contamination of corneal organ culture media in
french eye banks: results 2005-2006 (PO 1.1)
Nathalie Delesalle, Afssaps, Saint-Denis France
- Collaborative microbiological control studies of cornea organ culture
media: results of 6 studies (PO 1.2)
Nathalie Delesalle, Afssaps, Saint-Denis France
- External quality control of cornea organ culture media:
results 2005-2006 (PO 1.3)
Nathalie Delesalle, Afssaps, Saint-Denis France
- Management of corneal perforations and deep ulcers with small diameter
grafts (PO 1.4)
Dariusz Dobrowolski MD, District Railway Hospital, Katowice Poland
- Repair of corneal endothelium after mechanical damage under tissue
culture and hypothermic conditions (PO 1.5)
Katerina Jirsova Mgt, PhD, Faculty of Medicine, Charles University, Prague Czech Republic
- Prevalence of reactivity for human T-cell Lymphoma Virus (HTLV) in
donors of Central Eye Bank of Iran between 2005 and 2007 (PO 1.6)
Mozhgan Rezaei Kanavi MD, Central Eye Bank of Iran, Teheran Iran
- Automatic estimation of morphometric parameters in alizarine red stained
images of corneal endothelium (PO 1.7)
Alfredo Ruggeri MD, Prof., University of Padova, Padova Italy
- Manually pre-dissected donor corneas for Descemet stripping endothelial
keratoplasty (DSEK) (PO 1.8)
Jacqueline van der Wees MD, Netherlands Institute for innovative ocular surgery NIIOS,
Rotterdam, Netherlands
- Preliminary clinical results of Descemet membrane endothelial
keratoplasty (PO 1.9)
Jacqueline van der Wees MD, Netherlands Institute for innovative ocular surgery NIIOS,
Rotterdam, Netherlands
- Physical examination of potential cornea donors: what should we
look for? (PO 1.10)
Marja Van Wijk MD, PhD, BIS Foundation, Leiden Netherlands
- Temperature stable transport of organ cultured corneas (PO 1.11)
C. Meltendorf, Department of Ophthalmology Frankfurt am Main, Germany
- Limited availability of potential donors: reasons and suggestions for
improvement (PO 1.12)
Katja Rosenbaum, Eye Hospital & Lions Cornea Bank NRW, University Heinrich-
Heine, Duesseldorf Germany
- In vitro safety of Moxifloxacin for intraocular application (PO 1.13)
Raffael Liegl, University Eye Hospital of Ludwig-Maximilian-University, Munich Germany
- Limbal-conjunctival autograft transplantation for recurrent
pterygium (PO 1.14)
Damir Bosnar MD, Lions Croatian Eye Bank, Eye Clinic ‘Svjetlost’, Zagreb Croatia
- Prognosis in repeat keratoplasty: per indication analysis in a large mono-
centric cohort (PO 1.15)
Daniel Boehringer MD, University Eye Hospital, Freiburg Germany
- The screening for transmissive spongiform encephalopathy of ocular
tissue donors (PO 1.16)
Magdalena Netukova, TBI International Eye Bank of Prague, Prague Czech Republic
- Production of microparticles by corneal endothelium: potential implication in
corneal graft (PO 1.17)
Martin Barrali, CHU Jean Minjoz Clinique d’Ophtalmologie, France
- Modelling informed consent for transplant recipients of cornea (PO 1.18)
Mirjana Nasić , Eye bank Centre, University hospital centre Zagreb, Croatia